Medigus(MDGS)
icon
搜索文档
Xylo Technologies Announces Plan to Implement ADS Ratio Change
Newsfilter· 2024-07-31 04:00
Tel Aviv, Israel, July 30, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo" and the "Company"), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle ("EV") and charging solutions, announced today that it plans a ratio change which will result in a reverse split of the Company's American Depositary Receipt, or ADR, program on the basis of one (1) new ADS for every 2.666666 old ADSs held. As a result, the number of ordinary shar ...
Xylo: Gix Internet Signed MOU for Investment and Merger with an AI- Robotics Company
Newsfilter· 2024-06-06 21:27
TEL AVIV, Israel, June 06, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo"), a technology-based company engaged in advanced innovative technologies, announced today that Gix Internet Ltd. ("Gix") (45.75% owned by Xylo) (TASE: GIX), signed a non-binding memorandum of understanding (MOU) with the shareholders of a robotics company specializing in artificial intelligence (AI) autonomous robotics solutions, mainly for logistics distributions in certain medical centers ("Robotics Company"). ...
Xylo Technologies Files its 2023 Annual Report on Form 20-F
Newsfilter· 2024-04-23 04:05
TEL AVIV, Israel, April 22, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo", or the "Company"), formerly known as Medigus Ltd., a technology-based company engaged in advanced innovative technologies, announced the filing of its 2023 Annual Report on Form 20-F with the Securities and Exchange Commission. Xylo's 2023 Annual Report on Form 20-F includes audited financial statements for the year ended December 31, 2023. The report can be accessed on the company's investor relations website ...
Medigus(MDGS) - 2023 Q4 - Annual Report
2024-04-23 04:02
公司业务策略变化 - 公司自2019年开始进行了业务策略上的重大变化,包括拓展医疗设备行业以外的其他行业,放弃了商业化MUSE系统的策略,出售了Odysight.ai的股权,并将投资多元化到新的市场和行业[16] 公司财务状况 - 截至2023年12月31日,公司累计亏损达1.016亿美元,2023年实现的总营业亏损约为2,330万美元,2022年实现的总营业亏损约为1,380万美元[17] - 公司预计未来至少一年内将继续出现重大亏损,管理层计划通过利用财务资源继续资助其运营,但无法保证能够成功获得所需的融资,否则业务和运营结果将受到重大影响[17] 宏观经济影响 - 全球经济和宏观经济状况可能会对公司的运营结果产生重大不利影响,金融市场的极端波动已经对公司股价和资本市场准入产生了不利影响[18] 隐私和数据安全 - 公司及其子公司受到严格和不断变化的与隐私、数据保护和数据安全相关的法律、法规、标准和合同义务的约束,实际或被视为未能遵守这些义务可能会损害公司业务[20] - 预计各地区将继续提出和颁布有关隐私、数据保护和信息安全的新法律、法规和行业标准,这可能会对公司业务产生影响,例如欧盟的GDPR和UK GDPR等法规[21] 美国隐私法案 - 加利福尼亚通过了加利福尼亚消费者隐私法(CCPA),为加利福尼亚消费者提供新的数据隐私权利和对覆盖公司的新操作要求[24] - 加利福尼亚隐私权利法案可能增加公司的合规成本和潜在责任[24] - 加利福尼亚隐私权利法案可能标志着更严格的美国州和联邦隐私立法的开始[24] 公司业务风险 - Gix Internet的主要客户在2023年和2022年分别占其综合收入的87%和68%[32] - Gix Internet高度依赖于与主要客户的重要协议,任何协议变动可能对其业务、财务状况和运营结果产生不利影响[33] - Gix Internet可能无法产生足够的现金流来满足其债务义务或资助其他流动性需求[33] 技术风险 - Gix Internet可能无法保护其系统、技术和基础设施免受网络攻击[39] - 随着人工智能监管框架的发展,Gix Internet的业务、财务状况和运营结果可能会受到不利影响[40] 公司股权结构 - 我们持有Gix Internet 45.75%的股份,有权增持至48.11%[109] - 我们持有Eventer 46.21%的股份,其收入主要来自销售线上和线下活动门票[110] - 我们持有Jeffs' Brands 34.11%的股份,其主要经营线上消费品业务[112]
Medigus(MDGS) - 2023 Q2 - Quarterly Report
2023-09-29 05:21
Exhibit 99.1 MEDIGUS LTD. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2023 TABLE OF CONTENTS Interim Condensed Consolidated Statements of Financial Position 2 to 3 Interim Condensed Consolidated Statements of Loss and Other Comprehensive Loss 4 Interim Condensed Consolidated Statements of Changes in Equity 5 to 6 Interim Condensed Consolidated Statements of Cash Flows 7 to 8 Notes to Interim Condensed Consolidated Financial Statements 9 to 57 1 MEDIGUS LTD. INTERIM CONDENSED CONSOLIDA ...
Medigus(MDGS) - 2022 Q4 - Annual Report
2023-05-04 05:21
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commissi ...